InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

26 April 2025

Name:	PEPLIN, INC. (PLI)
Date of Listing:	09 October 2007
Date of Delisting:	30 November 2009

Stock Exchange Status: (updated daily)

This entity was delisted from the Australian Securities Exchange on 30 November 2009.

Legal Status: (updated monthly)

To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. We have not therefore verified the current legal status of this entity. If you have questions about your shareholding, as we say elsewhere, they may be taken up here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. You will need to seek independent tax advice in relation to Capital Gains Tax or other tax matters but any other enquiries relating to your shareholding in the company should be followed up via our online form here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

PEPLIN, INC.(PLI)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

REGISTRY:

Level 1, 200 Mary Street Brisbane QLD 4000

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 7 3229 9860
RegistryWebsite RegistryEmail

Company details

Address: Level 2 , Brisbane Portal , 1 Breakfast Creek Road , NEWSTEAD , QLD, AUSTRALIA, 4006
Tel: (07) 3250 1200 Fax: (07) 3250 1299

Date first listed: 09/10/2007
Company Secretary:
Sector: Industry Group:
Activities: The Company is the successor entity to Peplin Limited ("Peplin") a former ASX-listed development stage pharmaceutical company which undertook a restructure by schemes of arrangement resulting in it becoming a wholly-owned subsidiary of the Company

News & Events

Expand this box to read and print

delisted following completion of the merger with LEO Pharma A/S.	30/11/2009
we understand that for each CDI held in respect of Peplin Shares as at 8 pm, 11 November 2009 (Brisbane time) the consideration was US$0.8495 in cash, without interest; and for every 20 CDIs held in respect of a Peplin Option as at the Record Date, an amount in cash, without interest, equal to the difference between the per share merger consideration of US$16.99 and the exercise price of the Peplin Options (A$16.80)	30/11/2009
company announces that it has completed its merger with LEO Pharma A/S (LEO) after obtaining the approval of the majority of Peplin stockholders	12/11/2009
we understand that on or about this date the company undertook, proposed to undertake or was the subject of the following corporate action: - merge with LEO Pharma A/S - this corporate event may appear elsewhere in this company record	12/11/2009
the securities of Peplin, Inc. (the "Company") will be suspended from quotation immediately, in accordance with the timetable for the proposed merger with LEO Pharma A/S (the "Merger"), following receipt of an announcement confirming that the Merger was approved at a special meeting of holders of common stock and CHESS Depositary Interests earlier today	06/11/2009

ASX Announcements (courtesy of ASX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Tom Wiggans	Chairman	16/10/2007
David Smith	Company Secretary

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.